ArticleOncotarget2016

Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.

Yanan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.